SCHEMBL24601222

SCHEMBL24601222

CC(C)(O)O[C@@H]1CC(CO)OC1n1cnc2c(N)nc(Cl)nc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 2/20 0.52
PDE3A Q14432 2/20 0.52
PNP P00491 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
ADORA3 P0DMS8 8/20 0.52
ADORA2A P29274 4/20 0.52
ADORA1 P30542 3/20 0.52
PDE2A O00408 1/20 0.52
ADRA1A P35348 1/20 0.52
NT5E P21589 4/20 0.48
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA9 Q16790 1/20 0.46
ADORA2B P29275 1/20 0.45
P2RY1 P47900 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20333764 1.00 PDE4D (0.52) PDE4DPDE3APNPLMNATP53
SCHEMBL20333318 0.88 PDE4D (0.52) PDE4DPDE3APNPLMNATP53
SCHEMBL25955271 0.85 ADORA3 (0.52) SMN1; SMN2ADORA3ADORA2AADORA1ADORA2B
SCHEMBL24601458 0.84 ADORA3 (0.50) PDE4DPDE3APNPLMNATP53
SCHEMBL14396881 0.84 ADORA2A (0.61) ADORA3ADORA2AADORA1ADORA2B
SCHEMBL20059149 0.83 ADORA3 (0.60) PDE4DPDE3APNPLMNATP53
SCHEMBL3436979 0.81 PDE4D (0.66) PDE4DPDE3APNPLMNATP53
SCHEMBL19959557 0.81 PDE4D (0.66) PDE4DPDE3APNPLMNATP53
SCHEMBL3436977 0.81 PDE4D (0.66) PDE4DPDE3APNPLMNATP53
SCHEMBL19003202 0.81 TYMP (0.43) PDE4DSMN1; SMN2ADORA3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022143740-A1 ADENOSINE A3 RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF 浙江春禾医药科技有限公司 2022-07-07 WO disclosed